Catecholaminergic effects on ventricular repolarization during inhibition of the rapid component of the delayed

Brian R Overholser1, Xiaomei Zheng, James E Tisdale

  • 1Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Purdue University, West Lafayette, Indiana 46202, USA. boverhol@purdue.edu

Pharmacotherapy
|October 30, 2008
PubMed

Insights

Catecholamines prolonged ventricular repolarization during inhibition of the rapid component of the delayed rectifier potassium current (I(Kr)). This suggests counteracting mechanisms may contribute to an arrhythmogenic substrate during adrenergic activation with I(Kr) inhibition.

Area of Science:

  • Cardiovascular Physiology
  • Electrophysiology
  • Pharmacology

Background:

  • The rapid component of the delayed rectifier potassium current (I(Kr)) is crucial for ventricular repolarization.
  • Inhibition of I(Kr) is associated with QT prolongation and increased risk of arrhythmias.
  • Catecholamines influence cardiac electrophysiology through adrenergic receptors.

Purpose of the Study:

  • To investigate the effects of catecholamines on ventricular repolarization.
  • To determine these effects specifically during inhibition of I(Kr).

Main Methods:

  • Isolated perfused guinea pig heart model.
  • Administration of sparfloxacin to inhibit I(Kr).
  • Infusion of catecholamine admixtures (epinephrine and norepinephrine) during I(Kr) inhibition.
  • Measurement of left ventricular action potential duration (APD) at 90% and 30% repolarization (APD(90) and APD(30)).

Main Results:

  • Sparfloxacin administration significantly increased APD(90) and APD(30).
  • Subsequent catecholamine infusions during I(Kr) inhibition further increased APD(90) and APD(30).
  • A statistically significant net prolongation of ventricular repolarization was observed.

Conclusions:

  • Catecholamines cause a net prolongation of ventricular repolarization when I(Kr) is partially inhibited.
  • This finding suggests that counteracting mechanisms are activated.
  • These mechanisms may contribute to an arrhythmogenic substrate during adrenergic activation in the context of I(Kr) inhibition.
Abstract

Related Concept Videos

Cardiac Action Potential01:30

Cardiac Action Potential

Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase of...